Pfizer Fights Off Shareholder Lawsuit

Published: Jul 09, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Pfizer Inc won the dismissal Tuesday of a long-running shareholder class action accusing the company of misleading investors about the safety of its Celebrex and Bextra pain-relieving drugs.

The ruling by U.S. District Judge Laura Taylor Swain in New York came ahead of a Sept. 9 trial in the case, which investors launched in 2004 and followed an earlier ruling precluding testimony by the plaintiffs' damages expert.

Help employers find you! Check out all the jobs and post your resume.

Back to news